meta-analysis | Q815382 |
scholarly article | Q13442814 |
P2093 | author name string | Ye Wu | |
Yafeng Li | |||
Huirong Liu | |||
Jinghui Lei | |||
Suli Zhang | |||
Pengli Wang | |||
P2860 | cites work | Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages | Q74532728 |
Autoantibodies isolated from preeclamptic patients induce endothelial dysfunction via interaction with the angiotensin II AT1 receptor | Q86521061 | ||
International union of pharmacology. XXIII. The angiotensin II receptors | Q28138041 | ||
An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo | Q28578913 | ||
Meta-DiSc: a software for meta-analysis of test accuracy data. | Q31048578 | ||
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events | Q33693990 | ||
Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity | Q33748680 | ||
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia | Q34040304 | ||
Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy | Q34379583 | ||
The angiotensin II type 1 receptor and receptor-associated proteins | Q34408092 | ||
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease | Q34581918 | ||
Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism | Q35040206 | ||
Agonistic AT(1) receptor autoantibody increases in serum of patients with refractory hypertension and improves Ca(2+) mobilization in cultured rat vascular smooth muscle cells | Q36295460 | ||
CaMK4 Gene Deletion Induces Hypertension | Q36366241 | ||
The possible role of chromosome X variability in hypertensive familiarity | Q37207832 | ||
Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms | Q37470858 | ||
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms | Q38093493 | ||
Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases | Q38207936 | ||
Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia | Q38908359 | ||
Angiotensin II receptors and angiotensin II receptor antagonists. | Q40846126 | ||
Relationship between autoantibody to the angiotensin II-1 receptor and cardiovascular manifestations of Graves' disease | Q43487033 | ||
Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction | Q43939628 | ||
Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension | Q44162378 | ||
Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation | Q44218760 | ||
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
NASH: A global health problem | Q44967242 | ||
Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
Are most maternal deaths from pre-eclampsia avoidable? | Q46325585 | ||
Angiotensin II receptor type 1 autoantibodies promote endothelial microparticles formation through activating p38 MAPK pathway | Q46922047 | ||
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. | Q48284904 | ||
Increased susceptibility to metabolic syndrome in adult offspring of angiotensin type 1 receptor autoantibody-positive rats. | Q51361582 | ||
Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. | Q52933863 | ||
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation. | Q53501591 | ||
Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. | Q54782424 | ||
Coronary Heart Disease Risk Factors and Mortality | Q58811851 | ||
[Study of autoantibodies against the G-protein-coupled beta 2- and alpha 1-adrenergic and AT1 receptors in patients with primary hypertension] | Q73775849 | ||
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pre-eclampsia | Q61335 |
arterial hypertension | Q41861 | ||
autoantibody | Q785022 | ||
meta-analysis | Q815382 | ||
P304 | page(s) | e3494 | |
P577 | publication date | 2016-04-01 | |
P1433 | published in | Medicine | Q15716652 |
P1476 | title | The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies | |
P478 | volume | 95 |
Q50077615 | Autoantibodies against angiotensin and adrenergic receptors: more than a biomarker? |
Q40153619 | Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease. |
Q47646654 | Avoiding excessive pregnancy weight gain to obtain better pregnancy outcomes in Taiwan |
Q96230486 | Increased AT2R expression is induced by AT1R autoantibody via two axes, Klf-5/IRF-1 and circErbB4/miR-29a-5p, to promote VSMC migration |
Q50096185 | The mechanisms behind decreased internalization of angiotensin II type 1 receptor |
Search more.